Lawsuit claims protesters were a Hamas “propaganda arm” and that Students for Justice in Palestine knew of the attack before ...

In recent years, CBD (cannabidiol) has emerged as a natural remedy, capturing the attention of health enthusiasts and ...

August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new ...

The go-karts themselves are sleek, modern machines – predominantly black with striking yellow and orange accents that practically scream “I am serious business” despite being in a venue where the ...

She has tested several CBD creams for pain. “The cooling sensation lasts a while, and it has helped me continue to go about my day during a sciatica flare-up,” she says. “The cream comes in ...

These products — starting with the unmatched Royal CBD Cream (Cool Relief Balm), known for its fast-acting relief — will help you manage your pain and get back to living. With a stunning 21% of ...

To relieve diverticulitis pain fast try applying a heating pad, resting, taking acetaminophen (Tylenol) for pain relief, and following a liquid or low-fiber diet during a flare-up. Long-term ...

“I feel like I still haven't made it yet,” he tells Complex. “I’ve got a long way to go.” That kind of hunger has kept him pushing forward, even as the streaming world has changed dramatically in the ...

The 19-year-old from Launceston, Cornwall, first noticed swelling and pain in his testicle in October ... he said. “It was fast-spreading and I thought I could spend the last couple weeks ...

“Notably, neuropathic corneal pain falls into this category, and our application for Fast Track designation marks a significant milestone in our commitment to addressing the urgent needs of ...

Urcosimod is currently being evaluated in a phase 2 trial evaluating it's efficacy and safety in adults with neuropathic corneal pain. OKYO Pharma has filed a Fast Track designation application ...

“Fast track was first introduced by FDA to expedite development and review of drugs to treat serious conditions lacking any FDA-approved drug,” commented Gary S. Jacob, Ph.D., Chief Executive Officer ...